I. Gill

A phase 1a clinical trial of LYM‐1 monoclonal antibody serotherapy in patients with refractory b cell malignancies

S. Martin, P. Nichols, A. Sherrod, 1989, Hematological oncology.

Synergistic antitumor effects of interleukin 2 and the monoclonal Lym-1 against human Burkitt lymphoma cells in vitro and in vivo.

A. Mazumder, E. Hu, I. Gill, 1989, Cancer research.

No evidence of acute cardiovascular complications of chemotherapy for testicular cancer: an analysis of the Testicular Cancer Intergroup Study.

D. Stablein, L. Einhorn, R. Weiss, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of carboplatin in endometrial and cervical carcinomas.

F. Muggia, I. Gill, 1992, Seminars in oncology.

Optimizing Dose-Intensity: Combining Carboplatin with Cisplatin

F. Muggia, I. Gill, 1991 .

High dose intensity of cisplatin and etoposide in adenocarcinoma of unknown primary.

F. Muggia, S. Grunberg, P. Guaglianone, 1991, Anticancer research.

Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry.

R. Tarone, E. Reed, F. Muggia, 1991, Carcinogenesis.

Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum--DNA adducts.

M. Christian, E. Reed, F. Muggia, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies.

R. Tarone, E. Reed, F. Muggia, 1993, Cancer research.

Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitro.

E. Reed, F. Muggia, M. Dabholkar, 1992, Environmental health perspectives.

Treatment of cancer-associated hypercalcemia. Double-blind comparison of rapid and slow intravenous infusion regimens of pamidronate disodium and saline alone.

R. Theriault, R. Navari, S. Madajewicz, 1994, Archives of internal medicine.